Latest Articles

Open Access
Bayesian Approaches in Exploring Gene-environment and Gene-gene Interactions: A Comprehensive Review
NA SUN, YU WANG, JIADONG CHU, QIANG HAN and YUEPING SHEN

Cancer Genomics & Proteomics December 2023, 20 (6suppl) 669-678; DOI: https://doi.org/10.21873/cgp.20414
Open Access
(S)-3-(3-Fluoro-4-Methoxybenzyl)-5,6,7-Trimethoxychroman-4-One Suppresses the Proliferation of Huh7 Cells by Up-regulating P21 and Inducing G₂/M Phase Arrest
HAELIM YOON, JUNHO LEE, SANGIL KWON, SEUNG-YONG SEO and SAYEON CHO

Cancer Genomics & Proteomics December 2023, 20 (6suppl) 754-762; DOI: https://doi.org/10.21873/cgp.20422
Open Access
Pathogenetic Dichotomy in Angioleiomyoma
IOANNIS PANAGOPOULOS, KRISTIN ANDERSEN, MARTA BRUNETTI, LUDMILA GORUNOVA, ILYÁ KOSTOLOMOV, WANJA KILDAL, HANNE REGINE HOGNESTAD, INGVILD LOBMAIER, FRANCESCA MICCI and SVERRE HEIM

Cancer Genomics & Proteomics November 2023, 20 (6) 556-566; DOI: https://doi.org/10.21873/cgp.20405
Open Access
Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation
XIAOMIAO FAN, ZIMIN SONG, WENGUANG QIN, TING YU, BAOGANG PENG and YUQIN SHEN

Cancer Genomics & Proteomics November 2023, 20 (6) 602-616; DOI: https://doi.org/10.21873/cgp.20409
Open Access
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival
HYUNWOO YOO and HYUN-SOO KIM

Cancer Genomics & Proteomics November 2023, 20 (6) 626-636; DOI: https://doi.org/10.21873/cgp.20411
Open Access
p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors
AEJAZ NASIR, MALIK K. AHMED, JAMES J. SALLER, EVITA B. HENDERSON-JACKSON, MOKENGE P. MALAFA, TIMOTHY J. YEATMAN and DOMENICO COPPOLA

Cancer Genomics & Proteomics November 2023, 20 (6) 522-530; DOI: https://doi.org/10.21873/cgp.20402
Open Access
Hsa_circ_0079557 Promotes the Proliferation of Colorectal Cancer Cells Through the hsa_circ_0079557/miR-502-5p/CCND1 Axis
CHAO YU, XUE HUANG, RENLI HUANG, PEIQI WANG, ZONGDA CAI, ZEYI GUO, QINGNAN LAN, HAODI CAO and JINLONG YU

Cancer Genomics & Proteomics November 2023, 20 (6) 567-581; DOI: https://doi.org/10.21873/cgp.20406
Open Access
SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients
WEI-LUN HUANG, CHI-WEN LUO, HUEI-SHAN LIN, CHAO-MING HUNG, FANG-MING CHEN, SIN-HUA MOI and MEI-REN PAN

Cancer Genomics & Proteomics November 2023, 20 (6) 582-591; DOI: https://doi.org/10.21873/cgp.20407
Open Access
Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61
GERD BAUERSCHMITZ, SILKE HÜCHEL, JULIA GALLWAS and CARSTEN GRÜNDKER

Cancer Genomics & Proteomics November 2023, 20 (6) 531-538; DOI: https://doi.org/10.21873/cgp.20403
Open Access
Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma
JUHEE PARK, EUN HYE LEE, HYUNCHAE SIM, ANN-YAE NA, SO YOUNG CHOI, JAE-WOOK CHUNG, YUN-SOK HA, TAE GYUN KWON, SANGKYU LEE and JUN NYUNG LEE

Cancer Genomics & Proteomics November 2023, 20 (6) 592-601; DOI: https://doi.org/10.21873/cgp.20408

Main menu

User menu

Search

Latest Articles

Pages